Table 2.
The hazard ratio for overall survival in different subgroups: tumor type, disease stage and cut-off value
| No. | HR | 95%CI | P value | |
|---|---|---|---|---|
| Tumor type | ||||
| Colorectal cancer | 5 | 0.505 | 0.399-0.640 | <0.001 |
| Breast cancer | 1 | 0.242 | 0.139-0.422 | <0.001 |
| Lung Adenocarcinoma | 1 | 0.687 | 0.535-0.883 | 0.003 |
| Nasopharyngeal Carcinoma | 2 | 0.695 | 0.502-0.963 | 0.029 |
| Gastric cancer | 5 | 0.609 | 0.504-0.738 | <0.001 |
| Upper tract urothelial carcinoma | 2 | 0.452 | 0.271-0.751 | 0.002 |
| Hepatocellular carcinoma | 2 | 0.296 | 0.195-0.448 | <0.001 |
| Small cell lung cancer | 1 | 0.721 | 0.582-0.893 | 0.003 |
| Esophageal Squamous cell carcinoma | 1 | 0.759 | 0.507-1.137 | 0.181 |
| Esophageal Carcinoma(Mixed) | 1 | 0.47 | 0.240-0.920 | 0.028 |
| Clear cell renal cell carcinoma | 2 | 0.473 | 0.335-0.668 | <0.001 |
| Glioblastoma | 1 | 0.785 | 0.357-0.979 | 0.04 |
| Disease stage | ||||
| non-metastatic | 5 | 0.61 | 0.54-0.72 | <0.001 |
| metastatic | 2 | 0.49 | 0.28-0.87 | <0.001 |
| mixed | 17 | 0.57 | 0.52-0.62 | <0.001 |
| Cut-off value | ||||
| ≤1.20 | 6 | 0.371 | 0.235-0.586 | <0.001 |
| >1.20 to <1.40 | 9 | 0.573 | 0.489-0.671 | <0.001 |
| ≥1.40 | 9 | 0.617 | 0.550-0.692 | <0.001 |
| Overall | 24 | 0.578 | 0.533-0.626 | <0.001 |